Patients Rising, Inc – Trademark Portfolio
Entity Type: 03
Patients Rising, Inc holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include PATIENTS RISING and PATIENTS RISING NOW. The owner is based in Washington, DC.
700 12th Street NW Suite 700
Washington, DC 20005
Showing of trademarks Trademarks
Trademark Classifications
Patients Rising, Inc's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Patients Rising, Inc have?
Patients Rising, Inc has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Patients Rising, Inc file in?
Patients Rising, Inc files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 45 (Legal & Security Services). Class 35 covers advertising; business management; business administration; office functions.
What are Patients Rising, Inc's most well-known trademarks?
Patients Rising, Inc's registered trademark portfolio includes well-known marks such as PATIENTS RISING and PATIENTS RISING NOW. These are among 2 currently registered trademarks in the portfolio.
What is Patients Rising, Inc's trademark registration success rate?
Patients Rising, Inc has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.